Proton therapy in lung cancer: Clinical outcomes and technical issues. A systematic review

Radiotherapy and Oncology

Volumn 86, Issue 2, 2008, Pages 154-164

  Widesott, Lamberto ^a   Amichetti, Maurizio ^a   Schwarz, Marco ^a  

^a ATreP Provincial Agency for Proton Therapy   (Italy)

Author keywords

Evidence based medicine; NSCLC; Proton therapy; Systematic review

Indexed keywords

CANCER STAGING; CLINICAL PRACTICE; COMPARATIVE STUDY; DOSIMETRY; HUMAN; LUNG CANCER; LUNG NON SMALL CELL CANCER; OUTCOME ASSESSMENT; PHOTON THERAPY; PRIORITY JOURNAL; PROTON THERAPY; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; REVIEW; RISK ASSESSMENT; SAFETY; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

CARCINOMA, NON-SMALL-CELL LUNG; DOSE-RESPONSE RELATIONSHIP, RADIATION; EVIDENCE-BASED MEDICINE; HUMANS; LUNG NEOPLASMS; NEOPLASM STAGING; OUTCOME ASSESSMENT (HEALTH CARE); PROTONS;

EID: 39149100618     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2008.01.003     Document Type: Review

References (81)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics 2006. CA Cancer J Clin 56 (2006) 106-130
2. van Rens M.T., de la Riviere A.B., Elbers H.R., et al. Prognostic assessment of 2,361 patients who underwent pulmonary resection for non-small cell lung cancer, stage I, II, and IIIA. Chest 117 (2000) 374-379
3. Rowell N.P., and Williams C.J. Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable): a systematic review. Thorax 56 (2001) 628-638
4. Sirzen F., Kjellen E., Sorenson S., et al. A systematic overview of radiation therapy effects in non-small cell lung cancer. Acta Oncol 42 (2003) 493-515
5. Kong F.M., Zhao L., and Hayman J.A. The role of radiation therapy in thoracic tumors. Hematol Oncol Clin North Am 20 (2006) 363-400
6. Jassem J. The role of radiotherapy in lung cancer: where is the evidence?. Radiother Oncol 83 (2007) 203-213
7. Dillman R.O., Herndon J., Seagren S.L., et al. Improved survival in stage III non-small-cell lung cancer: seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial. J Natl Cancer Inst 88 (1996) 1210-1215
8. Belderbos J.S., Heemsbergen W.D., De Jaeger K., et al. Final results of a Phase I/II dose escalation trial in non-small-cell lung cancer using three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 66 (2006) 126-134
9. Arriagada R., Komaki R., and Cox J.D. Radiation dose escalation in non-small cell carcinoma of the lung. Semin Radiat Oncol 14 (2004) 287-291
10. Grills I.S., Yan D., Martinez A.A., et al. Potential for reduced toxicity and dose escalation in the treatment of inoperable non-small-cell lung cancer: a comparison of intensity-modulated radiation therapy (IMRT), 3D conformal radiation, and elective nodal irradiation. Int J Radiat Oncol Biol Phys 57 (2003) 875-890
11. Schwarz M., Alber M., Lebesque J.V., et al. Dose heterogeneity in the target volume and intensity-modulated radiotherapy to escalate the dose in the treatment of non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 62 (2005) 561-570
12. Nagata Y., Negoro Y., Aoki T., et al. Clinical outcomes of 3D conformal hypofractionated single high-dose radiotherapy for one or two lung tumors using a stereotactic body frame. Int J Radiat Oncol Biol Phys 52 (2002) 1041-1046
13. Manon R.R., Jaradat H., Patel R., et al. Potential for radiation therapy technology innovations to permit dose escalation for non-small-cell lung cancer. Clin Lung Cancer 7 (2005) 107-113
14. Underberg R.W., van Sornsen de Koste J.R., Lagerwaard F.J., et al. A dosimetric analysis of respiration-gated radiotherapy in patients with stage III lung cancer. Radiat Oncol 31 (2006) 1-8
15. Ramsey C.R., Langen K.M., Kupelian P.A., et al. A technique for adaptive image-guided helical tomotherapy for lung cancer. Int J Radiat Oncol Biol Phys 64 (2006) 1237-1244
16. Silvano G. New radiation techniques for treatment of locally advanced non-small cell lung cancer (NSCLC). Ann Oncol 17 (2006) ii34-ii35
17. Christian J.A., Bedford J.L., Webb S., et al. Comparison of inverse-planned three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 67 (2007) 735-741
18. Moyers M.F., Miller D.W., Bush D.A., et al. Methodologies and tools for proton beam design for lung tumors. Int J Radiat Oncol Biol Phys 49 (2001) 1429-1438
19. Paganetti H., Jiang H., Adams J.A., et al. Monte Carlo simulations with time-dependent geometries to investigate effects of organ motion with high temporal resolution. Int J Radiat Oncol Biol Phys 60 (2004) 942-950
20. Paganetti H., Jiang H., and Trofimov A. 4D Monte Carlo simulation of proton beam scanning: modelling of variations in time and space to study the interplay between scanning pattern and time-dependent patient geometry. Phys Med Biol 50 (2005) 983-990
21. Engelsman M., and Kooy H.M. Target volume dose considerations in proton beam treatment planning for lung tumors. Med Phys 32 (2005) 3549-3557
22. Engelsman M., Rietzel E., and Kooy H.M. Four-dimensional proton treatment planning for lung tumors. Int J Radiat Oncol Biol Phys 64 (2006) 1589-1595
23. Kang Y., Zhang X., Chang J.Y., et al. 4D Proton treatment planning strategy for mobile lung tumors. Int J Radiat Oncol Biol Phys 67 (2007) 906-914
24. Lodge M., Pijls-Johannesma M., Stirk L., et al. A systematic literature review of the clinical and cost-effectiveness of hadron therapy in cancer. Radiother Oncol 83 (2007) 110-122
25. Olsen D.R., Bruland O.S., Frykholm G., et al. Proton therapy - a systematic review of clinical effectiveness. Radiother Oncol 83 (2007) 123-132
26. Brada M., Pijls-Johannesma M., and De Ruysscher D. Proton therapy in clinical practice: current clinical evidence. J Clin Oncol 25 (2007) 965-970
27. NHS centre for review and dissemination. Undertaking systematic reviews of research on effectiveness. York: NHS CRD; 2001.
28. Bush D.A., Slater J.D., Bonnet R., et al. Proton-beam radiotherapy for early-stage lung cancer. Chest 116 (1999) 1313-1319
29. Bush D.A., Slater J.D., Shin B.B., et al. Hypofractionated proton beam radiotherapy for stage I lung cancer. Chest 126 (2004) 1198-1203
30. Shioyama Y., Tokuuye K., Okumura T., et al. Clinical evaluation of proton radiotherapy for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 56 (2003) 7-13
31. Hata M., Tokuuye K., Kagei K., et al. Hypofractionated high-dose proton beam therapy for stage I non-small-cell lung cancer: preliminary results of a phase I/II clinical study. Int J Radiat Oncol Biol Phys 68 (2007) 786-793
32. Nihei K., Ogino T., Ishikura S., et al. High-dose proton beam therapy for stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 65 (2006) 107-111
33. Lee C.H., Tait D., Nahum A.E., et al. Comparison of proton therapy and conformal X-ray therapy in non-small cell lung cancer (NSCLC). Br J Radiol 72 (1999) 1078-1084
34. Chang J.Y., Zhang X., Wang X., et al. Significant reduction of normal tissue dose by proton radiotherapy compared with three-dimensional conformal or intensity-modulated radiation therapy in stage I or stage III non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 65 (2006) 1087-1096
35. ICRU Report 62. Prescribing, Recording, and Reporting Photon Beam Therapy (Supplement to ICRU Report 50), International Commission on Radiation Units and Measurements; 1999.
36. Satoh H., Okumura T., Yamashita Y.T., et al. Proton irradiation for non-small cell lung cancer. Arch Intern Med 158 (1998) 1379-1380
37. Bush D.A., Dunbar R.D., Bonnet R., et al. Pulmonary injury from proton and conventional radiotherapy as revealed by CT. Am J Roentgenol 172 (1999) 735-739
38. Bonnet R.B., Bush D., Cheek G.A., et al. Effects of proton and combined proton/photon beam radiation on pulmonary function in patients with resectable but medically inoperable non-small cell lung cancer. Chest 120 (2001) 1803-1810
39. Gridley D.S., Bonnet R.B., Bush D.A., et al. Time course of serum cytokines in patients receiving proton or combined photon/proton beam radiation for resectable but medically inoperable non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 60 (2004) 759-766
40. Harpole Jr. D.H., Herndon J.E., Young Jr. W.G., et al. Stage I nonsmall cell lung cancer. A multivariate analysis of treatment methods and patterns of recurrence. Cancer 76 (1995) 787-796
41. Fry W.A., Phillips J.L., and Menck H.R. Ten-years survey of lung cancer treatment and survival in hospitals in the United States: a national cancer data base report. Cancer 86 (1999) 1867-1876
42. Ou S.H., Zell J.A., Ziogas A., et al. Prognostic factors for survival of stage I nonsmall cell lung cancer patients: a population-based analysis of 19,702 stage I patients in the California Cancer Registry from 1989 to 2003. Cancer 110 (2007) 1532-1541
43. Fang L.C., Komaki R., Allen P., et al. Comparison of outcomes for patients with medically inoperable stage I non-small-cell lung cancer treated with two-dimensional vs. three-dimensional radiotherapy. Int J Radiat Oncol Biol Phys 66 (2006) 108-116
44. Zimmermann F.B., Bamberg M., Molls M., et al. Radiation therapy alone in early stage non-small cell lung cancer. Semin Surg Oncol 21 (2003) 91-97
45. Qiao X., Tullgren O., Lax I., et al. The role of radiotherapy in treatment of stage I non-small cell lung cancer. Lung Cancer 41 (2003) 1-11
46. Jeremic B., Classen J., and Bamberg M. Radiotherapy alone in technically operable, medically inoperable, early-stage (I/II) non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 54 (2002) 119-130
47. Uematsu M., Shioda A., Suda A., et al. Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small cell lung cancer: a 5-year experience. Int J Radiat Oncol Biol Phys 51 (2001) 666-670
48. Fukumoto S., Shirato H., Shimzu S., et al. Small-volume image-guided radiotherapy using hypofractionated, coplanar, and noncoplanar multiple fields for patients with inoperable stage I nonsmall cell lung carcinomas. Cancer 95 (2002) 1546-1553
49. Nagata Y., Takayama K., Matsuo Y., et al. Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int J Radiat Oncol Biol Phys 63 (2005) 1427-1431
50. Beitler J.J., Badine E.A., El Sayah D., et al. Stereotactic body radiation therapy for nonmetastatic lung cancer: an analysis of 75 patients treated over 5 years. Int J Radiat Oncol Biol Phys 65 (2006) 100-106
51. Nyman J., Johansson K.A., and Hultén U. Stereotactic hypofractionated radiotherapy for stage I non-small cell lung cancer-mature results for medically inoperable patients. Lung Cancer 51 (2006) 97-103
52. Xia T., Li H., Sun Q., et al. Promising clinical outcome of stereotactic body radiation therapy for patients with inoperable stage I/II non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 66 (2006) 117-125
53. Timmerman R., McGarry R., Yiannoutsos C., et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol 24 (2006) 4833-4839
54. Yoon S.M., Choi E.K., Lee S.W., et al. Clinical results of stereotactic body frame based fractionated radiation therapy for primary or metastatic thoracic tumors. Acta Oncol 45 (2006) 1108-1114
55. Fritz P., Kraus H.J., Muhlnickel W., et al. Stereotactic, single-dose irradiation of stage I non-small cell lung cancer and lung metastases. Radiat Oncol (2006) 1-30
56. Zimmermann F.B., Geinitz H., Schill S., et al. Stereotactic hypofractionated radiotherapy in stage I (T1-2 N0 M0) non-small-cell lung cancer (NSCLC). Acta Oncol 45 (2006) 796-801
57. Hof H., Muenter M., Oetzel D., et al. Stereotactic single-dose radiotherapy (radiosurgery) of early stage nonsmall-cell lung cancer (NSCLC). Cancer 110 (2007) 148-155
58. Hoyer M., Roed H., Hansen A.T., et al. Prospective study on stereotactic radiotherapy of limited stage non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 66 (2006) S128-S135
59. Onishi H., Araki T., Shirato H., et al. Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study. Cancer 101 (2004) 1623-1631
60. Miyamoto T., Baba M., Sugane T., et al. Carbon ion radiotherapy for stage I non-small cell lung cancer using a regimen of four fractions during 1 week. J Thorac Oncol 2 (2007) 916-926
61. Mountain C.F. The international system for staging lung cancer. Semin Surg Oncol 18 (2000) 106-115
62. Pastorino U. Lung cancer: diagnosis and surgery. Eur J Cancer 37 (2001) S75-S90
63. Endo C., Sagawa M., Sakurada A., et al. Surgical treatment of stage I non-small cell lung carcinoma. Ann Thorac Cardiovasc Surg 9 (2003) 283-289
64. Birim O., Kappetein A.P., Goorden T., et al. Proper treatment selection may improve survival in patients with clinical early-stage nonsmall cell lung cancer. Ann Thorac Surg 80 (2005) 1021-1026
65. Wisnivesky J.P., Bonomi M., Henschke C., et al. Radiation therapy for the treatment of unresected stage I-II non-small cell lung cancer. Chest 128 (2005) 1461-1467
66. Le Chevalier T., Arriagada R., Quoix E., et al. Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients. J Natl Cancer Inst 83 (1991) 417-423
67. Wu K.L., Jiang G.L., Liao Y., et al. Three-dimensional conformal radiation therapy for non-small-cell lung cancer: a phase I/II dose escalation clinical trial. Int J Radiat Oncol Biol Phys 57 (2003) 1336-1344
68. Huber R.M., Flentje M., Schmidt M., et al. Simultaneous chemoradiotherapy compared with radiotherapy alone after induction chemotherapy in inoperable stage IIIA or IIIB non-small-cell lung cancer: study CTRT99/97 by the Bronchial Carcinoma Therapy Group. J Clin Oncol 24 (2006) 4397-4404
69. El Sharouni S.Y., Kal H.B., Battermann J.J., et al. Sequential versus concurrent chemo-radiotherapy in inoperable stage III non-small cell lung cancer. Anticancer Res 26 (2006) 495-505
70. Eberhardt W., Pottgen C., and Stuschke M. Chemoradiation paradigm for the treatment of lung cancer. Nat Clin Pract Oncol 3 (2006) 188-199
71. Bernstein E.D., Herbert S.M., and Hanna N.H. Chemotherapy and radiotherapy in the treatment of resectable non-small-cell lung cancer. Ann Surg Oncol 13 (2006) 291-301
72. Schulz C.A., Harari P.M., and Mehta M.P. Multiple daily fractionation radiotherapy schedules in lung cancer. Curr Oncol Rep 3 (2001) 179-184
73. Yee D., Halperin R., Hanson J., et al. Phase I study of hypofractionated dose-escalated thoracic radiotherapy for limited-stage small-cell lung cancer. Int J Radiat Oncol Biol Phys 65 (2006) 466-473
74. Chapet O., Kong F.M., Lee J.S., et al. Normal tissue complication probability modeling for acute esophagitis in patients treated with conformal radiation therapy for non-small cell lung cancer. Radiother Oncol 77 (2005) 176-181
75. Belderbos J., Heemsbergen W., Hoogeman M., et al. Acute esophageal toxicity in non-small cell lung cancer patients after high dose conformal radiotherapy. Radiother Oncol 75 (2005) 157-164
76. Wei X., Liu H.H., Tucker S.L., et al. Risk factors for acute esophagitis in non-small-cell lung cancer patients treated with concurrent chemotherapy and three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 66 (2006) 100-107
77. Baum C., Alber M., Birkner M., et al. Robust treatment planning for intensity modulated radiotherapy of prostate cancer based on coverage probabilities. Radiother Oncol 78 (2006) 27-35
78. Unkelbach J., Chan T.C., and Bortfelld T. Accounting for range uncertainties in the optimization of intensity modulated proton therapy. Phys Med Biol 52 (2007) 2755-2773
79. Witte M.G., van der Geer J., Schneider C., et al. IMRT optimization including random and systematic geometric errors based on the expectation of TCP and NTCP. Med Phys 34 (2007) 3544-3555
80. Mechalakos J., Yorke E., Mageras G.S., et al. Dosimetric effect of respiratory motion in external beam radiotherapy of the lung. Radiother Oncol 71 (2004) 191-200
81. Schwarz M., van der Geer J., van Herk M., et al. Impact of geometrical uncertainties on 3D CRT and IMRT dose distributions for lung cancer treatment. Int J Radiat Oncol Biol Phys 65 (2006) 1260-1269